Zimmer Biomet Holdings Acquisition Integration Divestiture And Related Expenses decreased by 28.8% to $15.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 47.2%, from $10.60M to $15.60M. Over 3 years (FY 2022 to FY 2025), Acquisition Integration Divestiture And Related Expenses shows an upward trend with a 89.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels indicate an active M&A strategy, which can signal growth potential but also integration risk.
Acquisition, integration, and divestiture expenses include costs incurred to acquire, merge with, or sell off business u...
Highly dependent on corporate strategy; peers with aggressive M&A strategies will consistently report these costs.
other_acquisition_integration_divestiture_and_related_expenses| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.50M | $6.40M | $2.20M | -$5.50M | $11.80M | $2.90M | $1.30M | $7.90M | $7.30M | $5.30M | $400.00K | $5.20M | $4.40M | $13.70M | $10.60M | $78.90M | -$34.40M | $21.90M | $15.60M |
| QoQ Change | — | +326.7% | -65.6% | -350.0% | +314.5% | -75.4% | -55.2% | +507.7% | -7.6% | -27.4% | -92.5% | >999% | -15.4% | +211.4% | -22.6% | +644.3% | -143.6% | +163.7% | -28.8% |
| YoY Change | — | — | — | -466.7% | +84.4% | — | -40.9% | +243.6% | -38.1% | +82.8% | -69.2% | -34.2% | -39.7% | +158.5% | >999% | >999% | -881.8% | +59.9% | +47.2% |